59
Participants
Start Date
February 28, 2015
Primary Completion Date
October 23, 2019
Study Completion Date
October 23, 2019
Depot medroxyprogesterone acetate (DMPA)
DMPA will be administered every 12 weeks at the standard dose of 150 mg IM, beginning from week 3 of study enrollment and repeated at week 15.
Etonogestrel implant (Eng-Implant)
A standard nexplanon rod implant will be placed at study week 3 by a trained clinician.
Levonorgestrel intrauterine device (Lng-IUD)
A standard Mirena IUD will be placed at study week 3 by a trained clinician.
ParaGard® T 380A Intrauterine Copper Contraceptive
A standard ParaGuard IUD will be placed at study week 3 by a trained clinician.
Grady Health System, Atlanta
The Ponce de Leon Center of the Grady Health System, Atlanta
Emory Clinic, Atlanta
Emory University Clinical Research Network, Atlanta
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Lisa Haddad
OTHER